resources

press releases

IDRI in the news

hot topics

blog

reports

videos

publications

  view by category

  view by date


Press Releases

2014

IDRI Announces $11.9M Contract to Develop Thermostable TB Vaccine
Seattle, WA | November 19, 2014

IDRI Named "Outstanding Global Health Organization" by WGHA
Seattle, WA | August 21, 2014

IDRI'S Rhea Coler Recognized as Recipient of "Women to Watch in Life Science" Award
Seattle, WA | June 10, 2014

IDRI Receives $3.4 Million Grant Extension for TB Drug Discovery
Seattle, WA | March 24, 2014

2013

IDRI Announces Evolution of Leadership Roles
Seattle, WA | December 19, 2013

IDRI and Zydus Sign Agreement for Development of IDRI’s Vaccine Candidate for Visceral Leishmaniasis (Kala-Azar)
Seattle, WA | July 25, 2013

IDRI Moves Into New Space At 1616 Eastlake
Seattle, WA | May 7, 2013

IDRI and Medicago Report Positive Results for Phase I Clinical Trial for an H5N1 Vaccine
Seattle, WA | April 17, 2013

IDRI and Medicago to Present Data at the World Vaccine Congress
Seattle, WA | April 8, 2013

IDRI and Orangelife Register Rapid Diagnostic for Leprosy for Use in Brazil
Seattle, WA | January 24, 2013

2012

TB Vaccine Candidate Enters Clinical Testing
Seattle, WA | August 22, 2012

IDRI and Medicago Authorized to Initiate Trial for an H5N1 Vaccine
Seattle, WA | August 16, 2012

IDRI Receives $3.7 Million Grant for TB Drug Discovery
Seattle, WA | July 25, 2012

IDRI Expands Board, Adding Additional International Expertise
Seattle, WA | July 2, 2012

Seven Pharmaceutical Companies Join Academic Researchers to Speed TB Drug Discovery
Seattle, WA | June 25, 2012

Clinical Trial of Human Hookworm Vaccine Begins at Children's National Medical Center
Washington, DC | June 13, 2012

IDRI Signs Lease with Alexandria Real Estate Equities, Inc. for New Seattle Headquarters
Seattle, WA | May 30, 2012

AERAS and IDRI Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine
Rockville, MD | Seattle, WA | May 9, 2012

IDRI Quest for Leprosy Vaccine Closer to Reality with Help of Million Dollar Grant
Seattle, WA | March 8, 2012

First Vaccine Against Fatal Visceral Leishmaniasis Enters Clinical Trial
Seattle, WA | February 22, 2012

IDRI Supports the First Phase 1 Human Hookworm Vaccine Clinical Trial
Seattle, WA | January 31, 2012

IDRI Awarded Additional Funds for Novel TB Drugs
Seattle, WA | January 11, 2012

2011

Human trials initiated for new HIV vaccine
Seattle, WA | December 21, 2011

IDRI Announces New VP Tuberculosis Drug Development: Gail H. Cassell, PhD, to Join IDRI
Seattle, WA | December 7, 2011

IDRI to Present at India - US Forum: Dr. Christopher Fox to Discuss IDRI's Technology Transfer Efforts
Seattle, WA | November 29, 2011

Eli Lilly and Company Provides IDRI with Additional Funding for Identification of New Tuberculosis Therapies
Seattle, WA | November 17, 2011

IDRI Partners with Global Research Initiative ADITEC to Accelerate Human Vaccine Development
Seattle, WA | October 17, 2011

The Paul G. Allen Family Foundation Supports Launch of IDRI's TB Vaccine Clinical Program
Seattle, WA | October 12, 2011

GlaxoSmithKline Donates Scientific Equpment to Advance IDRI's Global Health Mission
Seattle, WA | October 3, 2011

IDRI Launches New and Improved Website
Seattle, WA | September 7, 2011

IDRI, USAID Strike New Collaboration for Malaria Vaccine Development
Seattle, WA | August 16, 2011

IDRI Announces New EVP Business Development & External Affairs
Seattle, WA | August 2, 2011

IDRI Announces Appointment of H. Stewart Parker as Chief Executive Officer
Seattle, WA | February 15, 2011

IDRI Awarded Grant from Bill and Melinda Gates Foundation to Identify Candidates for Novel TB Drugs
Seattle, WA | January 14, 2011

IDRI Receives DARPA Grant to Develop a Novel Vaccine to Combat Pandemic Flu
Seattle,WA | January 7, 2011

2010

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza
Seattle, WA | December 3, 2010

IDRI Awarded $790,200 Grant from US Government to Develop Pandemic Flu Vaccine With Cantacuzino Institute
Seattle, WA | December 3, 2010

IDRI Develops Novel Tuberculosis Vaccine, New Study in Science Reports
Seattle, WA | October 14, 2010


IDRI and Merial Enter into Research Collaboration
Seattle, WA | Duluth, GA | July 14, 2010

2009

The Lilly TB Drug Discovery Initiative Announces New Collaborator
Seattle, September 29, 2009

IDRI Initiates Therapeutic Vaccine Clinical Trial in Sudan Against Leishmaniasis
Seattle, WA | Aug 27, 2009

IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests
Seattle, WA | Nes Ziona, Israel | August 31, 2009

IDRI Awarded $314,500 Grant From Murdock Trust to Expand TB Drug Discovery Program
Seattle | June 25, 2009

IDRI Makes its Adjuvant Available to Increase Global Supply of Pandemic Vaccines
Seattle, WA | June 11, 2009

Global Health Research to Push for More U.S. Support: Dr. Steve Reed has been named Global Health Research Ambassador
Seattle, WA | January 14, 2009

2008

IDRI Awarded $7 Million Grant from the Bill & Melinda Gates Foundation to Fight Visceral Leishmaniasis in Africa
Seattle, WA | December 18, 2008

IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
Seattle, WA | November 20, 2008

IDRI Receives NIH Funding to Design Adjuvants to Improve New TB Vaccine Protection
Seattle, WA | August 26, 2008

3M Collaborates with Infectious Disease Research Institute on Vaccine Adjuvants
St. Paul, MN | May 1, 2008

New York Community Trust Awards Grant of $100,000 to Infectious Disease Research Institute for Early Detection Leprosy Tests
Seattle, WA | January 30, 2008

2007

Infectious Disease Research Institute Receives Grant from the Bill & Melinda Gates Foundation for Adjuvant Access and Development
Seattle, WA | December 4, 2007

Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
Seattle, WA | October 19, 2007

Infectious Disease Research Institute and Chembio to Develop Tests for Leishmaniasis and Leprosy
Seattle, WA | May 31, 2007


1616 Eastlake Avenue East, Suite 400, Seattle, Washington 98102 office@idri.org  |  P: (206) 381-0883  |  F: (206) 381-3678 © 1993-2014 Privacy Policy
Infectious Disease Research Institute